These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39004675)

  • 21. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.
    Wong P; Iwasaki M; Somervaille TC; So CW; Cleary ML
    Genes Dev; 2007 Nov; 21(21):2762-74. PubMed ID: 17942707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway.
    Hou S; Wang X; Guo T; Lan Y; Yuan S; Yang S; Zhao F; Fang A; Liu N; Yang W; Chu Y; Jiang E; Cheng T; Sun X; Yuan W
    Leukemia; 2023 Aug; 37(8):1626-1637. PubMed ID: 37393343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chromatin-binding protein Phf6 restricts the self-renewal of hematopoietic stem cells.
    Miyagi S; Sroczynska P; Kato Y; Nakajima-Takagi Y; Oshima M; Rizq O; Takayama N; Saraya A; Mizuno S; Sugiyama F; Takahashi S; Matsuzaki Y; Christensen J; Helin K; Iwama A
    Blood; 2019 Jun; 133(23):2495-2506. PubMed ID: 30917958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myc-Miz1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpα and Cebpδ.
    Zhang L; Li J; Xu H; Shao X; Fu L; Hou Y; Hao C; Li W; Joshi K; Wei W; Xu Y; Zhang F; Dai S; Breslin P; Zhang J; Zhang J
    Blood; 2020 Apr; 135(14):1133-1145. PubMed ID: 32040550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
    Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
    Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression].
    Kikushige Y
    Rinsho Ketsueki; 2016 Apr; 57(4):412-6. PubMed ID: 27169443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PHF6 mutations in adult acute myeloid leukemia.
    Van Vlierberghe P; Patel J; Abdel-Wahab O; Lobry C; Hedvat CV; Balbin M; Nicolas C; Payer AR; Fernandez HF; Tallman MS; Paietta E; Melnick A; Vandenberghe P; Speleman F; Aifantis I; Cools J; Levine R; Ferrando A
    Leukemia; 2011 Jan; 25(1):130-4. PubMed ID: 21030981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells.
    Domingues AF; Kulkarni R; Giotopoulos G; Gupta S; Vinnenberg L; Arede L; Foerner E; Khalili M; Adao RR; Johns A; Tan S; Zeka K; Huntly BJ; Prabakaran S; Pina C
    Elife; 2020 Jan; 9():. PubMed ID: 31985402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular synergy underlies the co-occurrence patterns and phenotype of
    Dovey OM; Cooper JL; Mupo A; Grove CS; Lynn C; Conte N; Andrews RM; Pacharne S; Tzelepis K; Vijayabaskar MS; Green P; Rad R; Arends M; Wright P; Yusa K; Bradley A; Varela I; Vassiliou GS
    Blood; 2017 Oct; 130(17):1911-1922. PubMed ID: 28835438
    [No Abstract]   [Full Text] [Related]  

  • 30. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
    Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
    Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
    Wang GG; Pasillas MP; Kamps MP
    Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.
    Li A; Yang Y; Gao C; Lu J; Jeong HW; Liu BH; Tang P; Yao X; Neuberg D; Huang G; Tenen DG; Chai L
    J Clin Invest; 2013 Oct; 123(10):4195-207. PubMed ID: 24051379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia.
    Dong S; Chen J
    BMC Cancer; 2015 Nov; 15():893. PubMed ID: 26559765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.
    Lynch JR; Salik B; Connerty P; Vick B; Leung H; Pijning A; Jeremias I; Spiekermann K; Trahair T; Liu T; Haber M; Norris MD; Woo AJ; Hogg P; Wang J; Wang JY
    Leukemia; 2019 Jun; 33(6):1400-1410. PubMed ID: 30622285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia.
    Supper E; Rudat S; Iyer V; Droop A; Wong K; Spinella JF; Thomas P; Sauvageau G; Adams DJ; Wong CC
    Nat Commun; 2021 Apr; 12(1):2482. PubMed ID: 33931647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RSPO2 inhibits BMP signaling to promote self-renewal in acute myeloid leukemia.
    Sun R; He L; Lee H; Glinka A; Andresen C; Hübschmann D; Jeremias I; Müller-Decker K; Pabst C; Niehrs C
    Cell Rep; 2021 Aug; 36(7):109559. PubMed ID: 34407399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax.
    Ye S; Xiong F; He X; Yuan Y; Li D; Ye D; Shi L; Lin Z; Zhao M; Feng S; Zhou B; Weng H; Hong L; Ye H; Gao S
    Theranostics; 2023; 13(1):77-94. PubMed ID: 36593968
    [No Abstract]   [Full Text] [Related]  

  • 38. Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells.
    van Gosliga D; Schepers H; Rizo A; van der Kolk D; Vellenga E; Schuringa JJ
    Exp Hematol; 2007 Oct; 35(10):1538-49. PubMed ID: 17889721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia.
    Zhang CC; Yan Z; Pascual B; Jackson-Fisher A; Huang DS; Zong Q; Elliott M; Fan C; Huser N; Lee J; Sung M; Sapra P
    Neoplasia; 2018 Jan; 20(1):1-11. PubMed ID: 29172076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia.
    Zhang H; Alberich-Jorda M; Amabile G; Yang H; Staber PB; Di Ruscio A; Welner RS; Ebralidze A; Zhang J; Levantini E; Lefebvre V; Valk PJ; Delwel R; Hoogenkamp M; Nerlov C; Cammenga J; Saez B; Scadden DT; Bonifer C; Ye M; Tenen DG
    Cancer Cell; 2013 Nov; 24(5):575-88. PubMed ID: 24183681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.